-
1
-
-
0032572611
-
Meta-analysis of studies on genetic variation in 5-Ht2A receptors and clozapine response
-
2
-
Arranz MJ, Munro J, Sham P, Kirov G, Murray RM, Collier DA, Kerwin RW (1998) Meta-analysis of studies on genetic variation in 5-Ht2A receptors and clozapine response. Schizophr Res 32(2):93-99
-
(1998)
Schizophr Res
, vol.32
, pp. 93-99
-
-
Arranz, M.J.1
Munro, J.2
Sham, P.3
Kirov, G.4
Murray, R.M.5
Collier, D.A.6
Kerwin, R.W.7
-
2
-
-
0034612110
-
Pharmacogenetic prediction of clozapine response
-
9215
-
Arranz MJ, Munro J, Birkett J, Bolonna A, Mancama D, Sodhi M, Lesch KP, Meyer JF, Sham P, Collier DA, Murray RM, Kerwin RW (2000) Pharmacogenetic prediction of clozapine response. Lancet 355(9215):1615-1616
-
(2000)
Lancet
, vol.355
, pp. 1615-1616
-
-
Arranz, M.J.1
Munro, J.2
Birkett, J.3
Bolonna, A.4
Mancama, D.5
Sodhi, M.6
Lesch, K.P.7
Meyer, J.F.8
Sham, P.9
Collier, D.A.10
Murray, R.M.11
Kerwin, R.W.12
-
3
-
-
34547469943
-
Pharmacogenetics and pharmacogenomics of schizophrenia: A rview of last decade of research
-
8
-
Arranz MJ, de Leon J (2007) Pharmacogenetics and pharmacogenomics of schizophrenia: a rview of last decade of research. Mol Psychiatry 12(8):707-747
-
(2007)
Mol Psychiatry
, vol.12
, pp. 707-747
-
-
Arranz, M.J.1
De Leon, J.2
-
4
-
-
0035116425
-
Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms: Tardive dyskinesia in schizophrenia
-
Basile VS, Ozdemir V, Masellis M, Meltzer HY, Lieberman JA, Potkin SG, Macciardi FM, Kennedy JL (2001), Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms: tardive dyskinesia in schizophrenia. Mol Psychiatry 6:230-234
-
(2001)
Mol Psychiatry
, vol.6
, pp. 230-234
-
-
Basile, V.S.1
Ozdemir, V.2
Masellis, M.3
Meltzer, H.Y.4
Lieberman, J.A.5
Potkin, S.G.6
MacCiardi, F.M.7
Kennedy, J.L.8
-
5
-
-
33645501005
-
Pharmacogenomics and antidepressant drugs
-
Binder EB, Holsboer F (2006), Pharmacogenomics and antidepressant drugs. Ann Med 38:82-94
-
(2006)
Ann Med
, vol.38
, pp. 82-94
-
-
Binder, E.B.1
Holsboer, F.2
-
6
-
-
0036796048
-
The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment
-
Brockmoller J, Kirchhainer J, Schmider J, Walter S, Sachse C, Muller-Oerlinghausen B et al (2002) The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment. Clin Pharmacol Ther 72:438-452
-
(2002)
Clin Pharmacol Ther
, vol.72
, pp. 438-452
-
-
Brockmoller, J.1
Kirchhainer, J.2
Schmider, J.3
Walter, S.4
Sachse, C.5
Muller-Oerlinghausen, B.6
-
7
-
-
0034889181
-
Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram
-
Brosen K, Naranjo CA (2001) Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram. Eur Neuropsychopharmacol 11:275-283
-
(2001)
Eur Neuropsychopharmacol
, vol.11
, pp. 275-283
-
-
Brosen, K.1
Naranjo, C.A.2
-
8
-
-
0037380942
-
Comparison of two CYP2D6 genotyping methods and assessment of genotype-phenotype relationships
-
4
-
Chou WH, Yan FX, Robbins-Weilert DK, Ryder TB, Liu WW, Perbost C, Fairchild M, de Leon J, Koch WH, Wedlung PJ (2003) Comparison of two CYP2D6 genotyping methods and assessment of genotype-phenotype relationships. Clin Chem 49(4):542-551
-
(2003)
Clin Chem
, vol.49
, pp. 542-551
-
-
Chou, W.H.1
Yan, F.X.2
Robbins-Weilert, D.K.3
Ryder, T.B.4
Liu, W.W.5
Perbost, C.6
Fairchild, M.7
De Leon, J.8
Koch, W.H.9
Wedlung, P.J.10
-
9
-
-
0033168459
-
Shattuck lecture-medical and societal consequences of the Human Genome Project
-
1
-
Collins FS (1999) Shattuck lecture-medical and societal consequences of the Human Genome Project. N Engl J Med 341(1):28-37
-
(1999)
N Engl J Med
, vol.341
, pp. 28-37
-
-
Collins, F.S.1
-
10
-
-
0036129136
-
Influence of monoamine oxidase a and serotonin receptor 2A polymorphisms in SSRI antidepressant activity
-
1
-
Cusin C, Serretti A, Zanardi R, Lattuada E, Rossini D, Lilli R, Lorenzi C, Smeraldi E (2002) Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity. Int J Neuropsychopharmacol 5(1):27-35
-
(2002)
Int J Neuropsychopharmacol
, vol.5
, pp. 27-35
-
-
Cusin, C.1
Serretti, A.2
Zanardi, R.3
Lattuada, E.4
Rossini, D.5
Lilli, R.6
Lorenzi, C.7
Smeraldi, E.8
-
11
-
-
0036073564
-
Cytochrome P450 phenotyping/genotyping in patients receiving antipsychotics: Useful aid to prescribing?
-
Dahl ML (2002) Cytochrome P450 phenotyping/genotyping in patients receiving antipsychotics: useful aid to prescribing? Clin Pharmacokinet 41:453-470
-
(2002)
Clin Pharmacokinet
, vol.41
, pp. 453-470
-
-
Dahl, M.L.1
-
12
-
-
29544449443
-
Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19
-
1
-
de Leon J, Armstrong SC, Cozza KL (2006) Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19. Psychosomatics 47(1):75-85
-
(2006)
Psychosomatics
, vol.47
, pp. 75-85
-
-
De Leon, J.1
Armstrong, S.C.2
Cozza, K.L.3
-
13
-
-
4344641185
-
The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder
-
4
-
Durham LK, Webb SM, Milos PM, Clary CM, Seymour AB (2004) The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder. Psychopharmacology 174(4):525-529
-
(2004)
Psychopharmacology
, vol.174
, pp. 525-529
-
-
Durham, L.K.1
Webb, S.M.2
Milos, P.M.3
Clary, C.M.4
Seymour, A.B.5
-
14
-
-
0036157319
-
Ethnicity and treatment response in schizophrenia: A comparison of 3 ethnic groups
-
1
-
Emsley RA, Roberts MC, Rataemane S, Pretorius J, Oosthuizen PP, Turner J, Niehaus DJ, KeyterN, Stein DJ (2002) Ethnicity and treatment response in schizophrenia: a comparison of 3 ethnic groups. J Clin Psychiatry 63(1):9-14
-
(2002)
J Clin Psychiatry
, vol.63
, pp. 9-14
-
-
Emsley, R.A.1
Roberts, M.C.2
Rataemane, S.3
Pretorius, J.4
Oosthuizen, P.P.5
Turner, J.6
Niehaus, D.J.7
Keytern8
Stein, D.J.9
-
15
-
-
0033569516
-
Pharmacogenomics: Translating functional genomics into rational therapeutics
-
5439
-
Evans WE, Relling MV (1999) Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286(5439):487-491
-
(1999)
Science
, vol.286
, pp. 487-491
-
-
Evans, W.E.1
Relling, M.V.2
-
16
-
-
5344225623
-
Population pharmacokinetic analysis of mirtazapine
-
7
-
Grasmäder K, Vewohlt PL, Kühn KU, Dragicevic A, von Widdern O, Zobel A, Hiemke C, Rietschel M, Maier W, Jaehde U, Rao ML (2004a) Population pharmacokinetic analysis of mirtazapine. Eur J Clin Pharmacol 60(7):473-480
-
(2004)
Eur J Clin Pharmacol
, vol.60
, pp. 473-480
-
-
Grasmäder, K.1
Vewohlt, P.L.2
Kühn, K.U.3
Dragicevic, A.4
Von Widdern, O.5
Zobel, A.6
Hiemke, C.7
Rietschel, M.8
Maier, W.9
Jaehde, U.10
Rao, M.L.11
-
17
-
-
19244365359
-
Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting
-
Grasmäder K, Vewohlt PL, Rietschel M, Dragicevic A, Müller M, Hiemke C, Freymann N, Zobel A, Maier W, Rao ML (2004b) Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting. Eur J Clin Pharmacol 60:329-336
-
(2004)
Eur J Clin Pharmacol
, vol.60
, pp. 329-336
-
-
Grasmäder, K.1
Vewohlt, P.L.2
Rietschel, M.3
Dragicevic, A.4
Müller, M.5
Hiemke, C.6
Freymann, N.7
Zobel, A.8
Maier, W.9
Rao, M.L.10
-
18
-
-
0035052252
-
Genetic variants of the serotonin system and weight change during clozapine treatment
-
Hong CF, Lin CH, Yu YWY, Yang KH, Tsai SJ (2001) Genetic variants of the serotonin system and weight change during clozapine treatment. Pharmacogenetics 11:265-268
-
(2001)
Pharmacogenetics
, vol.11
, pp. 265-268
-
-
Hong, C.F.1
Lin, C.H.2
Yu, Y.W.Y.3
Yang, K.H.4
Tsai, S.J.5
-
19
-
-
33646072813
-
Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder
-
Hu X-Z, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD, Xu K, Arnold PD, Richter MA, Kennedy JL, Murphy DL, Goldman D (2006) Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 78:815-826
-
(2006)
Am J Hum Genet
, vol.78
, pp. 815-826
-
-
Hu, X.-Z.1
Lipsky, R.H.2
Zhu, G.3
Akhtar, L.A.4
Taubman, J.5
Greenberg, B.D.6
Xu, K.7
Arnold, P.D.8
Richter, M.A.9
Kennedy, J.L.10
Murphy, D.L.11
Goldman, D.12
-
20
-
-
34347374871
-
Association between a functional serotonin transporter promoter polymorphism and Citalopram treatment in adult outpatients with major depression
-
7
-
Hu X-Z, Rush AJ, Charney D, Wilson AF, Sorant AJM, Papanicolaou GJ, Fava M, Trivedi MH, Wisniewski SR, Laje G, Paccock S, McMahon FJ, Manji H, Lipsky RH (2007) Association between a functional serotonin transporter promoter polymorphism and Citalopram treatment in adult outpatients with major depression. Arch Gen Psychiatry 64(7):783-792
-
(2007)
Arch Gen Psychiatry
, vol.64
, pp. 783-792
-
-
Hu, X.-Z.1
Rush, A.J.2
Charney, D.3
Wilson, A.F.4
Sorant, A.J.M.5
Papanicolaou, G.J.6
Fava, M.7
Trivedi, M.H.8
Wisniewski, S.R.9
Laje, G.10
Paccock, S.11
McMahon, F.J.12
Manji, H.13
Lipsky, R.H.14
-
21
-
-
1942421701
-
Pharmacogenetics of cytochrome P450 and its applications in drug therapy: The past, present and future
-
4
-
Ingelman-Sundberg M (2004) Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future. Trend Pharmacol Sci 25(4):193-200
-
(2004)
Trend Pharmacol Sci
, vol.25
, pp. 193-200
-
-
Ingelman-Sundberg, M.1
-
22
-
-
13544249943
-
Genetic polymorphisms of cytochrome P450 (CYP2D6): Clinical consequences, evolutionary aspects and functional diversity
-
1
-
Ingelman-Sundberg M (2005) Genetic polymorphisms of cytochrome P450 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics 5(1):6-13
-
(2005)
Pharmacogenomics
, vol.5
, pp. 6-13
-
-
Ingelman-Sundberg, M.1
-
23
-
-
0033009871
-
Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers
-
Jonsson EG, Nothen MM, Grunhage F, Farde L, Nakashima Y, Propping P, Sedvall GC (1999) Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 4:290-296
-
(1999)
Mol Psychiatry
, vol.4
, pp. 290-296
-
-
Jonsson, E.G.1
Nothen, M.M.2
Grunhage, F.3
Farde, L.4
Nakashima, Y.5
Propping, P.6
Sedvall, G.C.7
-
24
-
-
3142519666
-
Pharmacogenetics of antidepressants and antipsychotics: The contribution of allelic variations to the phenotype of drug response
-
Kirchhainer J, Nickchen K, Bauer M, Wong M-L, Licinio J, Roots I, Brockmöller J (2004) Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response. Mol Psychiatry 9:442-473
-
(2004)
Mol Psychiatry
, vol.9
, pp. 442-473
-
-
Kirchhainer, J.1
Nickchen, K.2
Bauer, M.3
Wong, M.-L.4
Licinio, J.5
Roots, I.6
Brockmöller, J.7
-
25
-
-
24044520963
-
Sequence analysis of the serotonin transporter and associations with antidepressant response
-
5
-
Kraft JB, Slager SL, McGrath PJ, Hamilton SP (2005) Sequence analysis of the serotonin transporter and associations with antidepressant response. Biol Psychiatry 58(5):374-381
-
(2005)
Biol Psychiatry
, vol.58
, pp. 374-381
-
-
Kraft, J.B.1
Slager, S.L.2
McGrath, P.J.3
Hamilton, S.P.4
-
26
-
-
33645944971
-
DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients
-
Lencz T, Robinson DG, Xu K, Ekholm J, Sevy S, Gunduz-Bruce H, Woerner MG, Kane JM, Goldman D, Malhotra AK (2006) DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients. Am J Psychiatry 163:529-531
-
(2006)
Am J Psychiatry
, vol.163
, pp. 529-531
-
-
Lencz, T.1
Robinson, D.G.2
Xu, K.3
Ekholm, J.4
Sevy, S.5
Gunduz-Bruce, H.6
Woerner, M.G.7
Kane, J.M.8
Goldman, D.9
Malhotra, A.K.10
-
27
-
-
0036283004
-
Pharmacogenetics of tardive dyskinesia: Comined analysis of 780 patients supports association with dopamine d3 receptor gene Ser9Gly polymorphism
-
1
-
Lerer B, Segman RH, Fangerau H, Daly AK, Basile VS, Cavallaro R, Aschauer HN, McCreadie RG, Ohlraun S, Ferrier N, Masellis M, Verga M, Scharfetter J, Rietschel M, Lovlie R, Levy UH, Meltzer HY, Kenney JL, Steen VM, Macciardi F (2002) Pharmacogenetics of tardive dyskinesia: comined analysis of 780 patients supports association with dopamine d3 receptor gene Ser9Gly polymorphism. Neuropsychopharmacology 27(1):105-119
-
(2002)
Neuropsychopharmacology
, vol.27
, pp. 105-119
-
-
Lerer, B.1
Segman, R.H.2
Fangerau, H.3
Daly, A.K.4
Basile, V.S.5
Cavallaro, R.6
Aschauer, H.N.7
McCreadie, R.G.8
Ohlraun, S.9
Ferrier, N.10
Masellis, M.11
Verga, M.12
Scharfetter, J.13
Rietschel, M.14
Lovlie, R.15
Levy, U.H.16
Meltzer, H.Y.17
Kenney, J.L.18
Steen, V.M.19
MacCiardi, F.20
more..
-
28
-
-
0030598907
-
Proposed schizophrenia-related gene polymorphis: Expression of the Ser9Gly mutant human dopanie D3 receptor with the Semliki Forest virus system
-
3
-
Lundstrom K, Turpin MP (1996) Proposed schizophrenia-related gene polymorphis: expression of the Ser9Gly mutant human dopanie D3 receptor with the Semliki Forest virus system. Biochem Biophys Res Commun 225(3):1068-1072
-
(1996)
Biochem Biophys Res Commun
, vol.225
, pp. 1068-1072
-
-
Lundstrom, K.1
Turpin, M.P.2
-
30
-
-
33646062299
-
Variaton in the gene encoding te serotonin 2A receptor is associated with outcome of antidepressant treatment
-
5
-
McMahon FJ, Buervenich S, Charney D, Lipsky R, Rush AJ, Wilson AF, Sorant AJ, Papanicolaou GJ, Laje G, Fava M, Trivedi MH, Wisniewski SR, Manji H (2006) Variaton in the gene encoding te serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet 78(5):804-814
-
(2006)
Am J Hum Genet
, vol.78
, pp. 804-814
-
-
McMahon, F.J.1
Buervenich, S.2
Charney, D.3
Lipsky, R.4
Rush, A.J.5
Wilson, A.F.6
Sorant, A.J.7
Papanicolaou, G.J.8
Laje, G.9
Fava, M.10
Trivedi, M.H.11
Wisniewski, S.R.12
Manji, H.13
-
31
-
-
0035805390
-
Serotonin-2A-receptor and transporter polymorphisms: Lack of association in patients with major depression
-
2
-
Minov C, Baghai TC, Schüle C, Zwanzger P, Schwarz MJ, Zill P, Rupprecht R, Bondy B (2001) Serotonin-2A-receptor and transporter polymorphisms: lack of association in patients with major depression. Neurosci Lett 303(2):119-122
-
(2001)
Neurosci Lett
, vol.303
, pp. 119-122
-
-
Minov, C.1
Baghai, T.C.2
Schüle, C.3
Zwanzger, P.4
Schwarz, M.J.5
Zill, P.6
Rupprecht, R.7
Bondy, B.8
-
32
-
-
0642371335
-
Pharmocogenetics of antidepressant medication intolerance
-
Murphy GM, Kremer C, Rodrigues HE, Schatzberg BA, Schatzberg AF (2003) Pharmocogenetics of antidepressant medication intolerance. Am J Psychiatry 160:1830-1835
-
(2003)
Am J Psychiatry
, vol.160
, pp. 1830-1835
-
-
Murphy, G.M.1
Kremer, C.2
Rodrigues, H.E.3
Schatzberg, B.A.4
Schatzberg, A.F.5
-
33
-
-
4644303054
-
Investigation of serotonin-related genes in antidepressant response
-
Peters EJ, Slager SL, McGrath PJ, Knowles JA, Hamilton SP (2004) Investigation of serotonin-related genes in antidepressant response. Mol Psychiatry 9:879-889
-
(2004)
Mol Psychiatry
, vol.9
, pp. 879-889
-
-
Peters, E.J.1
Slager, S.L.2
McGrath, P.J.3
Knowles, J.A.4
Hamilton, S.P.5
-
34
-
-
0035861049
-
Potential role of pharmacogenomics in reducing adverse drug reactions, a systematic review
-
18
-
Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W (2001) Potential role of pharmacogenomics in reducing adverse drug reactions, a systematic review. JAMA 286(18):2270-2279
-
(2001)
JAMA
, vol.286
, pp. 2270-2279
-
-
Phillips, K.A.1
Veenstra, D.L.2
Oren, E.3
Lee, J.K.4
Sadee, W.5
-
35
-
-
0037097014
-
Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism
-
9323
-
Reynolds GP, Zhang ZJ, Zhang XB (2002) Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism. Lancet 359(9323):2086-2087
-
(2002)
Lancet
, vol.359
, pp. 2086-2087
-
-
Reynolds, G.P.1
Zhang, Z.J.2
Zhang, X.B.3
-
36
-
-
13244262700
-
Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response
-
2
-
Reynolds GP, Yao Z, Zhang X, Sun J, Zhang Z (2005) Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response. Eur Neuropsychopharmacol 15(2):143-151
-
(2005)
Eur Neuropsychopharmacol
, vol.15
, pp. 143-151
-
-
Reynolds, G.P.1
Yao, Z.2
Zhang, X.3
Sun, J.4
Zhang, Z.5
-
37
-
-
0036043220
-
The genetic basis of variability in drug responses
-
1
-
Roden DM, George AL Jr (2002) The genetic basis of variability in drug responses. Nat Rev Drug Discov 1(1):37-44
-
(2002)
Nat Rev Drug Discov
, vol.1
, pp. 37-44
-
-
Roden, D.M.1
George Jr., A.L.2
-
38
-
-
18744412116
-
Association between -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder
-
3
-
Sato K, Yoshida K, Takahashi H, Ito K, Kamata M, Higuchi H, Shimizu T, Itoh K, Inoue K, Tezuka T, Suzuki T, Ohkubo T, Sugawara K, Otani K (2002) Association between -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder. Neuropsychobiology 46(3):136-140
-
(2002)
Neuropsychobiology
, vol.46
, pp. 136-140
-
-
Sato, K.1
Yoshida, K.2
Takahashi, H.3
Ito, K.4
Kamata, M.5
Higuchi, H.6
Shimizu, T.7
Itoh, K.8
Inoue, K.9
Tezuka, T.10
Suzuki, T.11
Ohkubo, T.12
Sugawara, K.13
Otani, K.14
-
39
-
-
0034609249
-
Pharmacogenetics of the cloazapine response
-
9228
-
Schumacher J, Schulze TG, Wienker TF, Rietschel M, Nothen MM (2000) Pharmacogenetics of the cloazapine response. Lancet 356(9228):506-507
-
(2000)
Lancet
, vol.356
, pp. 506-507
-
-
Schumacher, J.1
Schulze, T.G.2
Wienker, T.F.3
Rietschel, M.4
Nothen, M.M.5
-
40
-
-
0033667902
-
Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: Additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility
-
4
-
Segman RH, Heresco-Ley U, Finkel B, Inbar R, Neeman T, Schlafman M, Dorevitch A, Yakir A, Lerner A, Goltser T, Shelevoy A, Lerer B (2000) Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility. Psychopharmacology 152(4):408-413
-
(2000)
Psychopharmacology
, vol.152
, pp. 408-413
-
-
Segman, R.H.1
Heresco-Ley, U.2
Finkel, B.3
Inbar, R.4
Neeman, T.5
Schlafman, M.6
Dorevitch, A.7
Yakir, A.8
Lerner, A.9
Goltser, T.10
Shelevoy, A.11
Lerer, B.12
-
41
-
-
17744392199
-
Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia
-
2
-
Segman RH, Heresco-Levy U, Finkel B., Goltser T, Shalem R, Schlafman M, Dorevitsch A, Yakir A, Greenberg D, Lerner A, Lerer B (2001) Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia. Mol Psychiatry 6(2):225-229
-
(2001)
Mol Psychiatry
, vol.6
, pp. 225-229
-
-
Segman, R.H.1
Heresco-Levy, U.2
Finkel, B.3
Goltser, T.4
Shalem, R.5
Schlafman, M.6
Dorevitsch, A.7
Yakir, A.8
Greenberg, D.9
Lerner, A.10
Lerer, B.11
-
42
-
-
33847257284
-
Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients
-
Serretti A, Kato M, de Ronchi D, Kinoshita T (2007) Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol Psychiatry 12:247-257
-
(2007)
Mol Psychiatry
, vol.12
, pp. 247-257
-
-
Serretti, A.1
Kato, M.2
De Ronchi, D.3
Kinoshita, T.4
-
43
-
-
0029551796
-
Association between clozapine response and allelic variation in the 5-HT2C receptor gene
-
1
-
Sodhi MS, Arranz MJ, Curtis D, Ball DM, Sham P, Roberts GW, Price J, Collier DA, Kerwin RW (1995) Association between clozapine response and allelic variation in the 5-HT2C receptor gene. Neuroreport 7(1):169-172
-
(1995)
Neuroreport
, vol.7
, pp. 169-172
-
-
Sodhi, M.S.1
Arranz, M.J.2
Curtis, D.3
Ball, D.M.4
Sham, P.5
Roberts, G.W.6
Price, J.7
Collier, D.A.8
Kerwin, R.W.9
-
44
-
-
0038130873
-
Polymorphic drug metabolism (CYP2D6) and utilisation of psychotropic drugs in hospitalised psychiatric patients: A retrospective study.
-
Tamminga WJ, Wemer J, Oosterhuis B, de Boer A, Vrackx S, Drenth BF et al. (2003) Polymorphic drug metabolism (CYP2D6) and utilisation of psychotropic drugs in hospitalised psychiatric patients: a retrospective study. Eur J Clin Pharmacol 59:57-64
-
(2003)
Eur J Clin Pharmacol
, vol.59
, pp. 57-64
-
-
Tamminga, W.J.1
Wemer, J.2
Oosterhuis, B.3
De Boer, A.4
Vrackx, S.5
Drenth, B.F.6
-
45
-
-
0028909857
-
Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors.
-
Tecott LH, Sun LM, Akana SF et al. (1995) Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors. Nature 374:542-546
-
(1995)
Nature
, vol.374
, pp. 542-546
-
-
Tecott, L.H.1
Sun, L.M.2
Akana, S.F.3
-
46
-
-
13444301359
-
Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients
-
Wu S, Xing Q, Gao R, Li X, Gu N, Feng G, He L (2005) Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients. Neurosci Lett 376:1-4
-
(2005)
Neurosci Lett
, vol.376
, pp. 1-4
-
-
Wu, S.1
Xing, Q.2
Gao, R.3
Li, X.4
Gu, N.5
Feng, G.6
He, L.7
-
47
-
-
0034103054
-
Identification of polymorphic loci in the promoter region of the serotonin 5HT2C receptor gene and their association with obesity and type II diabetes
-
Yuan X, Yamada K, Ishiyama-Shigemoto S, Koyama W, Nonaka K (2000) Identification of polymorphic loci in the promoter region of the serotonin 5HT2C receptor gene and their association with obesity and type II diabetes. Diabetologia 43:373-376
-
(2000)
Diabetologia
, vol.43
, pp. 373-376
-
-
Yuan, X.1
Yamada, K.2
Ishiyama-Shigemoto, S.3
Koyama, W.4
Nonaka, K.5
|